The interplay between Peptostreptococcus and Fusobacterium as novel signatures in colorectal cancer recurrence.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
16S rRNA gene sequencing and LC-MS metabolomic profiling
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Furthermore, a previously unrecognized link between pathobionts and metabolites relevant to recurrence was reported, which requires further validation in a larger independent cohort. Video Abstract.
[BACKGROUND] After resection surgery, recurrence occurs in more than 30% of colorectal cancer (CRC) patients.
- p-value P < 0.0001
- 95% CI 1.35-1.88
- HR 1.59
APA
Zhang Y, Zhang B, et al. (2026). The interplay between Peptostreptococcus and Fusobacterium as novel signatures in colorectal cancer recurrence.. Microbiome, 14(1). https://doi.org/10.1186/s40168-026-02378-w
MLA
Zhang Y, et al.. "The interplay between Peptostreptococcus and Fusobacterium as novel signatures in colorectal cancer recurrence.." Microbiome, vol. 14, no. 1, 2026.
PMID
41851757 ↗
Abstract 한글 요약
[BACKGROUND] After resection surgery, recurrence occurs in more than 30% of colorectal cancer (CRC) patients. Previous studies have highlighted the role of the gut microbiota in CRC initiation and progression; however, the microbial features associated with recurrence remain not completely understood. In particular, integrated multi-omics biomarkers, the interactions between microorganisms, as well as those between microbes and the host, and their relevance to recurrence risk require further investigation.
[RESULTS] In this study, 120 tumor mucosal samples collected during surgery from CRC patients underwent 16S rRNA gene sequencing and LC-MS metabolomic profiling. Recurrence status was determined through postoperative follow-up. Compared to the relatively minor variations in mucosal microbial and metabolomic signatures across different tumor node metastasis (TNM) stages, recurrent patients exhibited a distinct landscape. Machine learning analysis identified an integrated signature comprising five bacterial genera (Peptostreptococcus, Fusobacterium, Bacteroides, Porphyromonas, and Prevotella) and five metabolites (alanylglutamic acid, putrescine, arginine, histidine, and sebacic acid), which demonstrated strong discriminatory performance between recurrent and non-recurrent patients (AUC = 0.89). By integrating 10 biomarkers, a comprehensive risk score for patient stratification was derived. After adjusting for TNM stage, patients classified as high-risk had a significantly shorter recurrence-free survival (adjusted HR = 1.59, 95% CI 1.35-1.88, P < 0.0001). The microbial biomarkers Fusobacterium and Peptostreptococcus displayed positive correlation and were observed to co-aggregate and form dense dual-species biofilms. Further cellular and murine experiments revealed that P. anaerobius significantly enhanced the adhesion of F. nucleatum to tumor cells and its colonization of colonic mucosa. KEGG pathway analysis of differential metabolites identified enrichment of arginine and proline metabolism pathways in the recurrence group. Concurrently, arginine was found to disrupt F. nucleatum-P. anaerobius co-aggregation, while its metabolite putrescine significantly promoted dual-species biofilm formation.
[CONCLUSION] Our study identified integrated microbial and metabolic features associated with CRC recurrence and proposes an exploratory risk stratification framework. Furthermore, a previously unrecognized link between pathobionts and metabolites relevant to recurrence was reported, which requires further validation in a larger independent cohort. Video Abstract.
[RESULTS] In this study, 120 tumor mucosal samples collected during surgery from CRC patients underwent 16S rRNA gene sequencing and LC-MS metabolomic profiling. Recurrence status was determined through postoperative follow-up. Compared to the relatively minor variations in mucosal microbial and metabolomic signatures across different tumor node metastasis (TNM) stages, recurrent patients exhibited a distinct landscape. Machine learning analysis identified an integrated signature comprising five bacterial genera (Peptostreptococcus, Fusobacterium, Bacteroides, Porphyromonas, and Prevotella) and five metabolites (alanylglutamic acid, putrescine, arginine, histidine, and sebacic acid), which demonstrated strong discriminatory performance between recurrent and non-recurrent patients (AUC = 0.89). By integrating 10 biomarkers, a comprehensive risk score for patient stratification was derived. After adjusting for TNM stage, patients classified as high-risk had a significantly shorter recurrence-free survival (adjusted HR = 1.59, 95% CI 1.35-1.88, P < 0.0001). The microbial biomarkers Fusobacterium and Peptostreptococcus displayed positive correlation and were observed to co-aggregate and form dense dual-species biofilms. Further cellular and murine experiments revealed that P. anaerobius significantly enhanced the adhesion of F. nucleatum to tumor cells and its colonization of colonic mucosa. KEGG pathway analysis of differential metabolites identified enrichment of arginine and proline metabolism pathways in the recurrence group. Concurrently, arginine was found to disrupt F. nucleatum-P. anaerobius co-aggregation, while its metabolite putrescine significantly promoted dual-species biofilm formation.
[CONCLUSION] Our study identified integrated microbial and metabolic features associated with CRC recurrence and proposes an exploratory risk stratification framework. Furthermore, a previously unrecognized link between pathobionts and metabolites relevant to recurrence was reported, which requires further validation in a larger independent cohort. Video Abstract.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Comment on: "Interpretable machine learning model for predicting early recurrence of pancreatic cancer: integrating intratumoral and peritumoral radiomics with body composition".
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Impact of contrast-enhanced computed tomography surveillance frequency on survival outcomes in patients with stage I-III colorectal cancer: A propensity score-matched retrospective cohort study.
- Corrigendum to "TMEM176A drives anti-apoptotic signaling through TGM2-mediated ERK activation in gastric cancer" [Int. Immunopharmacol. 168 (2026) 115798].
- Dietary restriction genes as modulators of breast cancer risk through metabolic pathways.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.